In the study "Adverse Obstetric Outcomes in Pregnancies With Major Fetal Congenital Heart Defects," published in JAMA Pediatrics, researchers analyzed data from the Danish Fetal Medicine Database ...
Elucidating the roles of SLC25A1 and PSG1 would open pathways to novel preventive treatments for congenital heart defects linked with abnormalities of the placenta.